2021 Award Oral – Experimental Tubulointerstitial Disease

M Khan1,2,3,4,P  Nag3,5, K Giuliani2,3,5,X  Wang3,5, A Grivei3,5, W Hoy1,7, H Healy1,2,3,5, V Dewan1,7, G Gobe1,2,6, A Kassianos2,3,5  1NHMRC CKD CRE (CKD.QLD), University of Queensland , Brisbane,, Australia, 2Faculty of Medicine, University of Queensland, Brisbane,, Australia, 3Conjoint Internal Medicine Laboratory, Chemical Pathology, Pathology...
M Snelson M1, De Pasquale C1, Tan S1, Coughlan M1  1Department of Diabetes, Monash University, Mlebourne, Australia  Aim: To investigate the gut targeting mechanisms by which resistant starch (RS) supplementation may be protective against diabetic nephropathy.  Background: Dietary RS may be nephro-protective in...
P MEHTA 1,  T SLATTER 1,  R WALKER 1 1University of Otago, Dunedin, New Zealand Aim: To explore pathways through which amiloride reduces lithium-induced interstitial fibrosis. Background: Lithium therapy is associated with the development of nephrogenic diabetes insipidus (NDI), interstitial fibrosis and...
Recent Comments
    Categories